Large-scale purification and preliminary X-ray diffraction studies of human aspartylglucosaminidase

Proteins: Structure, Function and Genetics

Volumn 24, Issue 2, 1996, Pages 253-258

  Tikkanen, Ritva ^a   Rouvinen, Juha ^b   Törrönen, Anneli ^b   Kalkkinen, Nisse ^c   Peltonen, Leena ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

crystallization; glycosylasparaginase; lysosomes; protein purification

Indexed keywords

COMPLEMENTARY DNA; LYSOSOME ENZYME; N4 (BETA N ACETYLGLUCOSAMINYL)ASPARAGINASE; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; ASPARTYLGLYCOSAMINURIA; CRYSTAL STRUCTURE; CRYSTALLIZATION; ENZYME PURIFICATION; ENZYME SUBUNIT; HUMAN; HUMAN CELL; LEUKOCYTE; LYSOSOME STORAGE DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; X RAY DIFFRACTION;

ASPARTYLGLUCOSYLAMINASE; BLOTTING, WESTERN; CRYSTALLOGRAPHY, X-RAY; HUMANS; LEUKOCYTES; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 0029968087     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0134(199602)24:2<253::AID-PROT12>3.0.CO;2-M     Document Type: Article

References (20)

1. Aronson, N. N., Kuranda, J. K. Lysosomal degradation of Asn-linked glycoproteins. FASEB J. 3:2615-2622, 1989.
2. Ikonen, E., Julkunen, I., Tollersrud, O-K., Kalkkinen, N., Peltonen, L. Lysosomal aspartylglucosaminidase is processed to the active subunit complex in the endoplasmic reticulum. EMBO J. 12:295-302, 1993.
3. Tollersrud, O-K., Aronson, N. N. Purification and characterization of rat liver glycosylasparaginase. Biochem. J. 260:101-108, 1989.
4. Halila, R., Baumann, M., Ikonen, E., Enomaa, N., Peltonen, L. Human leucocyte aspartylglucosaminidase. Evidence for two different subunits in a more complex native structure. Biochem. J. 276.251-2562, 1991.
5. Baumann, M., Peltonen, L., Aula, P., Kalkkinen, N. Isolation of a human hepatic 60 kDa aspartylglucosaminidase consisting of three non-identical polypeptides. Biochem. J. 262:189-194, 1989.
6. Heiskanen, T., Tollersrud, O. K., Zhao, M., Peltonen, L. Large-scale purification of human aspartylglucosaminidase: Utilization of exceptional sodium dodecyl sulfate resistance. Protein Expression Purification 5:205-210, 1994.
7. 206 are needed for the catalytic activity of aspartylglugosaminidase. J. Biol. Chem. 270:4903-4907, 1995.
8. Rip, J. W., Coulter-Mackie, M. B., Rupar, C. A., Gordon, B. A. Purification and structure of human liver aspartylglucosaminidase. Biochem. J. 288:1005-1010, 1992.
9. Sato, M., Yamamoto, M., Imada, K., Katsube, Y. A highspeed data collection system for large-unit-cell crystals using an imaging plate as a detector. J. Appl. Crystallogr. 25:348-357, 1992.
10. Feigner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., Danielsen, M. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U.S.A. 84:7413-7417, 1987.
11. Tikkanen, R., Enomaa, N., Riikonen, A., Ikonen, E., Peltonen, L. intracellular sorting of aspartylglucosaminidase: The role of N-linked oligosaccharides and evidence of Man-6-P independent lysosomal targeting. DNA Cell Biol. 14: 305-312, 1995.
12. Enomaa, N., Heiskanen, T., Halila, R., Sormunen, R., Seppälä, R., Vihinen, M., Peltonen, L. Human aspartylglucosaminidase. A biochemical and immunocytochemical characterization of the enzyme in normal and aspartylglucosaminuria fibroblasts. Biochem. J. 286:613-618, 1992.
13. Matthews, B. W. Solvent content of protein crystals. J. Mol. Biol. 33:491-497, 1968.
14. Kaartinen, V., Williams, J. C., Tomich, J., Yates, J. R., Hood, L. E., Mononen, I. Glycoasparaginase from human leukocytes. Inactivation and covalent modification with diazo-oxonorvaline. J. Biol. Chem. 266:5860-5869, 1991.
15. Musil, D., Zucic, D., Turk, D., Engh, R. A., Mayr, I., Huber, R., Popovic, T., Turk, V., Towatari, T., Katunuma, N., Bode, W. The refined 2.15 Å X-ray crystal structure of human liver cathepsin B: The structural basis for its specificity. EMBO J. 10:2321-2330, 1991.
16. Fusek, M., Baudys, M., Metcalf, P. Purification and crystallization of human cathepsin D. J. Mol. Biol. 226:555-557, 1992.
17. Gulnik, S., Baldwin, E. T., Tarasova, N., Erickson, J. Human liver cathepsin D. Purification, crystallization and preliminary X-ray diffraction analysis of a lysosomal enzyme. J. Mol. Biol. 227:265-270, 1992.
18. Church, W. B., Swenson, L., Games, N. G., Mahuran, D. Crystallization of human beta-hexosaminidase B. J. Mol. Biol. 227:577-580, 1992.
19. Ikonen, E., Baumann, M., Grön, K., Syvänen, A-c., Enomaa, N., Halila, R., Aula, P., Peltonen, L. Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease. EMBO J. 10:51-58, 1991.
20. Pollitt, R. J., Jenner, F. A., Merskey, H. Aspartylglucosaminuria. An inborn error of metabolism associated with mental defect. Lancet 2:253-255, 1968.